4/9/19

Tactiva Therapeutics, an immuno-oncology company and UB partner, is poised for growth in 2019.

6/24/19

Lined with bird shelters and bat boxes, “Life Support” is a living art sculpture that will serve as a functional habitat for a wide variety of bats, birds and reptiles.

6/26/19

Aesku.NY, a UB partner, has growing operations on the Buffalo Niagara Medical Campus.

6/26/19

Study seeks to identify new genes associated with breast cancer risk in African American women.

6/27/19

TRELIS builds leadership capacity among women who work in geographic information science in higher education.

7/8/19

In the Democratic Republic of the Congo, peace and economic opportunity are percolating, thanks to UB efforts to develop a more inclusive coffee value chain.

7/8/19

Numerous smoking cessation therapies are on the market, but actually quitting for good is still a major challenge for many smokers. Now, a University at Buffalo researcher has been awarded a five-year, $2 million grant to investigate a novel therapy.

7/10/19

Study's findings on nitrogen dioxide suggest that China's air pollution standard for NO2 may need to be re-evaluated.

7/11/19

  People who narrowly avoid disaster do not necessarily escape tragedy unharmed, and their knowledge of the victims’ fate shapes how survivors respond to traumatic events, according to the results of a new paper by a UB psychologist.  

7/16/19

UB’s physics department is hosting a conference for Large Hadron Collider researchers this week.

7/17/19

UB researchers’ insights into a target that succeeded in animals but failed in humans reveal a new paradigm for screening Alzheimer’s drugs.